BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33965983)

  • 21. Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.
    Liberini V; Laudicella R; Balma M; Nicolotti DG; Buschiazzo A; Grimaldi S; Lorenzon L; Bianchi A; Peano S; Bartolotta TV; Farsad M; Baldari S; Burger IA; Huellner MW; Papaleo A; Deandreis D
    Eur Radiol Exp; 2022 Jun; 6(1):27. PubMed ID: 35701671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).
    Rouvière O; Souchon R; Lartizien C; Mansuy A; Magaud L; Colom M; Dubreuil-Chambardel M; Debeer S; Jaouen T; Duran A; Rippert P; Riche B; Monini C; Vlaeminck-Guillem V; Haesebaert J; Rabilloud M; Crouzet S
    BMJ Open; 2022 Feb; 12(2):e051274. PubMed ID: 35140147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
    Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
    Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Low Rate of Adherence to Checklist for Artificial Intelligence in Medical Imaging Criteria Among Published Prostate MRI Artificial Intelligence Algorithms.
    Belue MJ; Harmon SA; Lay NS; Daryanani A; Phelps TE; Choyke PL; Turkbey B
    J Am Coll Radiol; 2023 Feb; 20(2):134-145. PubMed ID: 35922018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality in MR reporting of the prostate – improving acquisition, the role of AI and future perspectives.
    Wang L; Margolis DJ; Chen M; Zhao X; Li Q; Yang Z; Tian J; Wang Z
    Br J Radiol; 2022 Mar; 95(1131):20210816. PubMed ID: 35119914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of AI in prostate MRI quality and interpretation: Opportunities and challenges.
    Kim H; Kang SW; Kim JH; Nagar H; Sabuncu M; Margolis DJA; Kim CK
    Eur J Radiol; 2023 Aug; 165():110887. PubMed ID: 37245342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial Intelligence for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the
    Turkbey B; Haider MA
    AJR Am J Roentgenol; 2022 Aug; 219(2):188-194. PubMed ID: 34877870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on prostate biopsy in the era of magnetic resonance imaging.
    Cicione A; De Nunzio C; Manno S; Damiano R; Posti A; Lima E; Tubaro A; Balloni F
    Minerva Urol Nefrol; 2018 Jun; 70(3):264-274. PubMed ID: 29595039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
    van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
    Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in the Use of Artificial Intelligence for Prostate Cancer Diagnosis from Multiparametric Imaging Data.
    Corradini D; Brizi L; Gaudiano C; Bianchi L; Marcelli E; Golfieri R; Schiavina R; Testa C; Remondini D
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantib Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study.
    Faiella E; Vertulli D; Esperto F; Cordelli E; Soda P; Muraca RM; Moramarco LP; Grasso RF; Beomonte Zobel B; Santucci D
    Tomography; 2022 Aug; 8(4):2010-2019. PubMed ID: 36006066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
    Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
    Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation and prospective clinical validation of AI-based planning and shimming techniques in cardiac MRI.
    Edalati M; Zheng Y; Watkins MP; Chen J; Liu L; Zhang S; Song Y; Soleymani S; Lenihan DJ; Lanza GM
    Med Phys; 2022 Jan; 49(1):129-143. PubMed ID: 34748660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of multiparametric magnetic resonance imaging (mpMRI) in localized prostate cancer.
    O'Connor L; Wang A; Walker SM; Yerram N; Pinto PA; Turkbey B
    Expert Rev Med Devices; 2020 May; 17(5):435-442. PubMed ID: 32275845
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI-algorithm for lesion detection and classification.
    Oerther B; Engel H; Nedelcu A; Schlett CL; Grimm R; von Busch H; Sigle A; Gratzke C; Bamberg F; Benndorf M
    Prostate; 2023 Jun; 83(9):871-878. PubMed ID: 36959777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-trained convolutional neural networks for automated detection of prostate cancer in multi-parametric MRI.
    Yang X; Liu C; Wang Z; Yang J; Min HL; Wang L; Cheng KT
    Med Image Anal; 2017 Dec; 42():212-227. PubMed ID: 28850876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-specific transfer learning for auto-segmentation in adaptive 0.35 T MRgRT of prostate cancer: a bi-centric evaluation.
    Kawula M; Hadi I; Nierer L; Vagni M; Cusumano D; Boldrini L; Placidi L; Corradini S; Belka C; Landry G; Kurz C
    Med Phys; 2023 Mar; 50(3):1573-1585. PubMed ID: 36259384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics.
    Kaneko M; Magoulianitis V; Ramacciotti LS; Raman A; Paralkar D; Chen A; Chu TN; Yang Y; Xue J; Yang J; Liu J; Jadvar DS; Gill K; Cacciamani GE; Nikias CL; Duddalwar V; Jay Kuo CC; Gill IS; Abreu AL
    Urol Clin North Am; 2024 Feb; 51(1):1-13. PubMed ID: 37945095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer.
    Chu TN; Wong EY; Ma R; Yang CH; Dalieh IS; Hung AJ
    Curr Urol Rep; 2023 May; 24(5):231-240. PubMed ID: 36808595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.